TAMBRIZA
Dead / Abandoned — Abandoned — no statement of use filed (as of 03 Feb 2014)
What this means for you
This application is over — abandoned 03 Feb 2014. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 85353319
- Mark type
- Stylized text
- Filed
- 22 Jun 2011
- Published for opposition
- 08 Nov 2011
- Abandoned
- 03 Feb 2014
- Attorney of record
- James M. McCarthy
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cardiovascular, cardiopulmonary, genitourinary, central nervous system, endocrine, gastrointestinal, gynecological, hematological, immunological, hormonal, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, sleep, urogenital, urological, neurodegenerative and viral related diseases and disorders; pharmaceutical preparations for the treatment of pain, sepsis, diabetes, apopecia, allergies, erectile dysfunction, sexual dysfunction, obesity, and HIV/AIDS
Owner
- Methylgene Inc., Montreal, CA
- Methylgene Inc., Montreal, CA
Prosecution history
- 03 Feb 2014 — ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
- 03 Feb 2014 — ABANDONMENT - NO USE STATEMENT FILED
- 27 Jul 2013 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Jul 2013 — SOU EXTENSION 3 GRANTED
- 25 Jun 2013 — SOU EXTENSION 3 FILED
- 24 Jul 2013 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 25 Jun 2013 — SOU TEAS EXTENSION RECEIVED
- 23 Jan 2013 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Jan 2013 — SOU EXTENSION 2 GRANTED
- 28 Dec 2012 — SOU EXTENSION 2 FILED
- 28 Dec 2012 — SOU TEAS EXTENSION RECEIVED
- 18 Jul 2012 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Jul 2012 — SOU EXTENSION 1 GRANTED
- 20 Jun 2012 — SOU EXTENSION 1 FILED
- 16 Jul 2012 — CASE ASSIGNED TO INTENT TO USE PARALEGAL